{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:42:41Z","timestamp":1784040161777,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1053\/j.jvca.2012.03.011","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T00:02:21Z","timestamp":1335225741000},"page":"563-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["An Evaluation of Factors Affecting Activated Coagulation Time"],"prefix":"10.1053","volume":"26","author":[{"given":"Yvonne P.J.","family":"Bosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Weerwind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patty J.","family":"Nelemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos G.","family":"Maessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baheramsjah","family":"Mochtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2012.03.011_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-0038-1649561","article-title":"Thrombin generation during cardiac surgery: Is heparin the ideal anticoagulant?","volume":"70","author":"Brister","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2012.03.011_bib2","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00000539-200005000-00013","article-title":"The in vitro effects of antithrombin III on the activated coagulation time in patients on heparin therapy","volume":"90","author":"Levy","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2012.03.011_bib3","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0022-5223(94)70150-4","article-title":"Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations","volume":"108","author":"Despotis","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2012.03.011_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jama.1966.03100180108036","article-title":"Activated coagulation time of whole blood","volume":"196","author":"Hattersley","year":"1966","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2012.03.011_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1051\/ject\/1995274197","article-title":"Correlation of ACT as measured with three commercially available devices with circulating heparin level during cardiac surgery","volume":"27","author":"Niles","year":"1995","journal-title":"J Extra Corpor Technol"},{"key":"10.1053\/j.jvca.2012.03.011_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jtcvs.2004.10.045","article-title":"Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass","volume":"130","author":"Avidan","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2012.03.011_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/026765919901400606","article-title":"Predictors for heparin resistance in patients undergoing coronary artery bypass grafting","volume":"14","author":"Ranucci","year":"1999","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2012.03.011_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1053\/j.jvca.2004.01.013","article-title":"Heparin resistance and antithrombin: Should it still be called heparin resistance?","volume":"18","author":"Levy","year":"2004","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2012.03.011_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF03022006","article-title":"Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgery","volume":"54","author":"Bar-Yosef","year":"2007","journal-title":"Can J Anaesth"},{"key":"10.1053\/j.jvca.2012.03.011_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/00000539-199709000-00005","article-title":"Antithrombin III during cardiac surgery: Effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation","volume":"85","author":"Despotis","year":"1997","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2012.03.011_bib11","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/j.1538-7836.2005.01363.x","article-title":"Molecular recognition mechanisms of thrombin","volume":"3","author":"Huntington","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2012.03.011_bib12","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood-2005-04-1710","article-title":"Directing thrombin","volume":"106","author":"Lane","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2012.03.011_bib13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0003-4975(94)90752-8","article-title":"Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulation","volume":"58","author":"Hashimoto","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2012.03.011_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1191\/0267659104pf711oa","article-title":"Determinants of antithrombin consumption in cardiac operations requiring cardiopulmonary bypass","volume":"19","author":"Ranucci","year":"2004","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2012.03.011_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0022-5223(19)38872-5","article-title":"The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass","volume":"85","author":"Esposito","year":"1983","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2012.03.011_bib16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1213\/00000539-200004000-00008","article-title":"Anticoagulation for cardiac surgery in patients receiving preoperative heparin: Use of the high-dose thrombin time","volume":"90","author":"Shore-Lesserson","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2012.03.011_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00000539-200101000-00013","article-title":"Low preoperative antithrombin activity causes reduced response to heparin in adult but not in infant cardiac-surgical patients","volume":"92","author":"Dietrich","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2012.03.011_bib18","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1213\/ANE.0b013e3181ce1ffa","article-title":"Heparin dose response is independent of preoperative antithrombin activity in patients undergoing coronary artery bypass graft surgery using low heparin concentrations","volume":"111","author":"Garvin","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2012.03.011_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1067\/mtc.2002.119060","article-title":"Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery","volume":"123","author":"Lemmer","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2012.03.011_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/bja\/87.6.844","article-title":"Heparin pretreatment does not alter heparin requirements during cardiopulmonary bypass","volume":"87","author":"Nicholson","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2012.03.011_bib21","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood.V94.7.2169.419k22_2169_2178","article-title":"\u201cNormal\u201d thrombin generation","volume":"94","author":"Butenas","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2012.03.011_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.moh.0000130314.33410.d7","article-title":"Thrombin generation assays: Accruing clinical relevance","volume":"11","author":"Hemker","year":"2004","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.jvca.2012.03.011_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000539-200207000-00004","article-title":"The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: A pilot investigation","volume":"95","author":"Koster","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2012.03.011_bib24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1213\/ANE.0b013e3181b79d09","article-title":"Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements","volume":"111","author":"Garvin","year":"2010","journal-title":"Anesth Analg"},{"issue":"suppl 2","key":"10.1053\/j.jvca.2012.03.011_bib25","first-page":"48","article-title":"Physiological function of tissue factor pathway inhibitor and interaction with heparins","volume":"30","author":"Sandset","year":"2000","journal-title":"Haemostasis"},{"key":"10.1053\/j.jvca.2012.03.011_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.trsl.2008.12.004","article-title":"Regulation of thrombin generation by TFPI in plasma without and with heparin","volume":"153","author":"Brodin","year":"2009","journal-title":"Transl Res"},{"key":"10.1053\/j.jvca.2012.03.011_bib27","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/00000542-199910000-00031","article-title":"Anticoagulation monitoring during cardiac surgery: A review of current and emerging techniques","volume":"91","author":"Despotis","year":"1999","journal-title":"Anesthesiology"},{"issue":"suppl","key":"10.1053\/j.jvca.2012.03.011_bib28","doi-asserted-by":"crossref","first-page":"188S","DOI":"10.1378\/chest.126.3_suppl.188S","article-title":"Heparin and low-molecular-weight heparin: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Hirsh","year":"2004","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2012.03.011_bib29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low-molecular-weight heparins","volume":"337","author":"Weitz","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2012.03.011_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.jvca.2004.01.014","article-title":"Decreased concentration of antithrombin after preoperative therapeutic heparin does not cause heparin resistance during cardiopulmonary bypass","volume":"18","author":"Linden","year":"2004","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2012.03.011_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-2004-869598","article-title":"Statins in atherothrombosis","volume":"4","author":"Colli","year":"2004","journal-title":"Semin Vasc Med"},{"key":"10.1053\/j.jvca.2012.03.011_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1191\/0267659106pf855oa","article-title":"A statistical analysis of factors predisposing patients to heparin resistance","volume":"21","author":"Chan","year":"2006","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2012.03.011_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1051\/ject\/1999314184","article-title":"5-Year incidence of thrombocytosis and the effect on heparin dose response and heparin requirements","volume":"31","author":"Gayoso","year":"1999","journal-title":"J Extra Corpor Technol"},{"key":"10.1053\/j.jvca.2012.03.011_bib34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1042\/bj2180725","article-title":"Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4","volume":"218","author":"Lane","year":"1984","journal-title":"Biochem J"},{"key":"10.1053\/j.jvca.2012.03.011_bib35","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1016\/S0021-9258(17)35610-7","article-title":"Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4","volume":"261","author":"Lane","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1053\/j.jvca.2012.03.011_bib36","first-page":"238","article-title":"Heparin binding to resting and activated platelets","volume":"74","author":"Horne","year":"1989","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2012.03.011_bib37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3181\/00379727-69-16693","article-title":"The relationship of heparin activity to platelet concentration","volume":"69","author":"Conley","year":"1948","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1053\/j.jvca.2012.03.011_bib38","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/j.1537-2995.2010.02586.x","article-title":"Effects of red blood cells on hemostasis","volume":"50","author":"Roeloffzen","year":"2010","journal-title":"Transfusion"},{"key":"10.1053\/j.jvca.2012.03.011_bib39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0003-4975(95)00821-7","article-title":"Response of kaolin ACT to heparin: Evaluation with an automated assay and higher heparin doses","volume":"61","author":"Despotis","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2012.03.011_bib40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/ajcp\/67.5.477","article-title":"Variation among commercial activated partial thromboplastin time reagents in response to heparin","volume":"67","author":"Shapiro","year":"1977","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.jvca.2012.03.011_bib41","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1055\/s-0038-1649659","article-title":"Standard and method independent units for heparin anticoagulant activities","volume":"70","author":"Hemker","year":"1993","journal-title":"Thromb Haemost"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077012001371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077012001371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:40:25Z","timestamp":1760946025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077012001371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1053077012001371"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2012.03.011","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Evaluation of Factors Affecting Activated Coagulation Time","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2012.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}